
Rhelixa
Developer of epigenome analysis technology designed to improve the efficiency and accuracy of life science research and development. The company's technology offers a wide range of solutions, includin...
Valuation
$17.2M
Latest known
Share Price
N/A
Total Raised
$5.5M
Last Round
N/A